Is Kodiak Sciences Stock a Good Investment?
Kodiak Sciences Investment Advice | KOD |
- Examine Kodiak Sciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Kodiak Sciences' leadership team and their track record. Good management can help Kodiak Sciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Kodiak Sciences' business and its evolving consumer preferences.
- Compare Kodiak Sciences' performance and market position to its competitors. Analyze how Kodiak Sciences is positioned in terms of product offerings, innovation, and market share.
- Check if Kodiak Sciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Kodiak Sciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Kodiak Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Kodiak Sciences is a good investment.
Sell | Buy |
Hold
Market Performance | Good | Details | |
Volatility | Unstable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Kodiak Sciences Stock
Researching Kodiak Sciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 78.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.92. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kodiak Sciences recorded a loss per share of 3.64. The entity had not issued any dividends in recent years.
To determine if Kodiak Sciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Kodiak Sciences' research are outlined below:
| Kodiak Sciences is way too risky over 90 days horizon | |
| Kodiak Sciences appears to be risky and price may revert if volatility continues | |
| Kodiak Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (260.49 M) with profit before taxes, overhead, and interest of 0. | |
| Kodiak Sciences has about 597.88 M in cash with (154.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Kodiak Sciences has a frail financial position based on the latest SEC disclosures | |
| Over 78.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Baker Bros. Advisors Lp of 42250 shares of Kodiak Sciences at 6.6036 subject to Rule 16b-3 |
Kodiak Sciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Kodiak Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Kodiak Sciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Kodiak Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Kodiak Sciences' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-03-16 | 2019-12-31 | -0.35 | -0.4 | -0.05 | 14 | ||
2019-03-27 | 2018-12-31 | -0.3 | -0.25 | 0.05 | 16 | ||
2020-08-10 | 2020-06-30 | -0.66 | -0.58 | 0.08 | 12 | ||
2020-05-11 | 2020-03-31 | -0.46 | -0.54 | -0.08 | 17 | ||
2020-11-09 | 2020-09-30 | -0.67 | -0.8 | -0.13 | 19 | ||
2021-11-09 | 2021-09-30 | -1.16 | -1.3 | -0.14 | 12 | ||
2019-05-15 | 2019-03-31 | -0.37 | -0.21 | 0.16 | 43 | ||
2023-03-28 | 2022-12-31 | -1.52 | -1.35 | 0.17 | 11 |
Know Kodiak Sciences' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Kodiak Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kodiak Sciences backward and forwards among themselves. Kodiak Sciences' institutional investor refers to the entity that pools money to purchase Kodiak Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 580.8 K | Silverarc Capital Management, Llc | 2024-09-30 | 500 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 495.2 K | Hudson Bay Capital Management Lp | 2024-09-30 | 493.5 K | Ikarian Capital, Llc | 2024-09-30 | 476.6 K | Bruce & Co Inc | 2024-09-30 | 423 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 361.2 K | Two Sigma Advisers, Llc | 2024-09-30 | 333.3 K | Goldman Sachs Group Inc | 2024-09-30 | 318.8 K | Baker Bros Advisors Lp | 2024-09-30 | 17.3 M | Blackrock Inc | 2024-09-30 | 3.9 M |
Kodiak Sciences' market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 357.84 M.Market Cap |
|
Kodiak Sciences' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.49) | (0.51) | |
| Return On Capital Employed | (0.73) | (0.69) | |
| Return On Assets | (0.49) | (0.51) | |
| Return On Equity | (1.13) | (1.07) |
Determining Kodiak Sciences' profitability involves analyzing its financial statements and using various financial metrics to determine if Kodiak Sciences is a good buy. For example, gross profit margin measures Kodiak Sciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Kodiak Sciences' profitability and make more informed investment decisions.
Please note, the presentation of Kodiak Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kodiak Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Kodiak Sciences' management manipulating its earnings.
Evaluate Kodiak Sciences' management efficiency
Kodiak Sciences has Return on Asset of (0.2672) % which means that on every $100 spent on assets, it lost $0.2672. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.715) %, meaning that it generated no profit with money invested by stockholders. Kodiak Sciences' management efficiency ratios could be used to measure how well Kodiak Sciences manages its routine affairs as well as how well it operates its assets and liabilities. As of February 1, 2025, Return On Tangible Assets is expected to decline to -0.51. The current year's Return On Capital Employed is expected to grow to -0.69. At present, Kodiak Sciences' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 78.3 M, whereas Net Tangible Assets are forecasted to decline to about 358.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.56 | 5.58 | |
| Tangible Book Value Per Share | 4.56 | 5.58 | |
| Enterprise Value Over EBITDA | 0.15 | 0.16 | |
| Price Book Value Ratio | 0.54 | 0.57 | |
| Enterprise Value Multiple | 0.15 | 0.16 | |
| Price Fair Value | 0.54 | 0.57 | |
| Enterprise Value | 244.3 M | 232.1 M |
The management team at Kodiak Sciences has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta 2.251 |
Basic technical analysis of Kodiak Stock
As of the 1st of February, Kodiak Sciences secures the Mean Deviation of 5.06, risk adjusted performance of 0.1591, and Downside Deviation of 6.14. Kodiak Sciences technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kodiak Sciences treynor ratio, and the relationship between the standard deviation and downside variance to decide if Kodiak Sciences is priced some-what accurately, providing market reflects its recent price of 6.4 per share. Given that Kodiak Sciences has jensen alpha of 1.13, we recommend you to check Kodiak Sciences's last-minute market performance to make sure the company can sustain itself at a future point.Kodiak Sciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kodiak Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kodiak Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kodiak Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kodiak Sciences' Outstanding Corporate Bonds
Kodiak Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kodiak Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kodiak bonds can be classified according to their maturity, which is the date when Kodiak Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Kodiak Sciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Kodiak Sciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1591 | |||
| Market Risk Adjusted Performance | 0.8098 | |||
| Mean Deviation | 5.06 | |||
| Semi Deviation | 5.28 | |||
| Downside Deviation | 6.14 | |||
| Coefficient Of Variation | 555.84 | |||
| Standard Deviation | 7.13 | |||
| Variance | 50.85 | |||
| Information Ratio | 0.1659 | |||
| Jensen Alpha | 1.13 | |||
| Total Risk Alpha | 0.5052 | |||
| Sortino Ratio | 0.1928 | |||
| Treynor Ratio | 0.7998 | |||
| Maximum Drawdown | 45.02 | |||
| Value At Risk | (9.57) | |||
| Potential Upside | 11.39 | |||
| Downside Variance | 37.66 | |||
| Semi Variance | 27.88 | |||
| Expected Short fall | (5.71) | |||
| Skewness | 0.8483 | |||
| Kurtosis | 3.27 |
| Risk Adjusted Performance | 0.1591 | |||
| Market Risk Adjusted Performance | 0.8098 | |||
| Mean Deviation | 5.06 | |||
| Semi Deviation | 5.28 | |||
| Downside Deviation | 6.14 | |||
| Coefficient Of Variation | 555.84 | |||
| Standard Deviation | 7.13 | |||
| Variance | 50.85 | |||
| Information Ratio | 0.1659 | |||
| Jensen Alpha | 1.13 | |||
| Total Risk Alpha | 0.5052 | |||
| Sortino Ratio | 0.1928 | |||
| Treynor Ratio | 0.7998 | |||
| Maximum Drawdown | 45.02 | |||
| Value At Risk | (9.57) | |||
| Potential Upside | 11.39 | |||
| Downside Variance | 37.66 | |||
| Semi Variance | 27.88 | |||
| Expected Short fall | (5.71) | |||
| Skewness | 0.8483 | |||
| Kurtosis | 3.27 |
Consider Kodiak Sciences' intraday indicators
Kodiak Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Kodiak Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 6.4 | |||
| Day Typical Price | 6.4 | |||
| Price Action Indicator | (0.20) | |||
| Period Momentum Indicator | (0.40) |
Kodiak Sciences Corporate Filings
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 7th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 23rd of April 2024 Other Reports | ViewVerify |
Kodiak Stock media impact
Far too much social signal, news, headlines, and media speculation about Kodiak Sciences that are available to investors today. That information is available publicly through Kodiak media outlets and privately through word of mouth or via Kodiak internal channels. However, regardless of the origin, that massive amount of Kodiak data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kodiak Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kodiak Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kodiak Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kodiak Sciences alpha.
Kodiak Sciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Kodiak Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Kodiak Sciences Corporate Management
| Tracy Chien | VP Controller | Profile | |
| Almas MSc | Senior Operations | Profile | |
| Victor MD | Chairman, CoFounder | Profile | |
| Michael Louie | Senior Officer | Profile | |
| CPA MBA | CFO VP | Profile | |
| Pablo MD | Senior Development | Profile | |
| Stephen Raillard | Senior Manufacturing | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Kodiak Sciences' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.